Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.60 |
---|---|
High | 2.65 |
Low | 2.53 |
Bid | 2.52 |
Offer | 2.58 |
Previous close | 2.61 |
Average volume | 288.63k |
---|---|
Shares outstanding | 27.84m |
Free float | 27.77m |
P/E (TTM) | -- |
Market cap | 72.67m USD |
EPS (TTM) | -1.30 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Vistagen to Present at the Stifel 2024 Healthcare Conference
- Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update
- Vistagen to Present at the 2024 Neuroscience Education Institute Congress
- Vistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024
- Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day
- Vistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
More ▼